Ebola medical therapy
|
Ebola Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Postmortem Care |
|
Case Studies |
|
Ebola medical therapy On the Web |
|
American Roentgen Ray Society Images of Ebola medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Guillermo Rodriguez Nava, M.D. [2]
Overview
No specific antiviral drug has demonstrated effectiveness against Ebola infection. Management is primarily supportive and symptomatic. The following basic interventions, when used early, can significantly improve the chances of survival: providing intravenous fluids and balancing electrolytes, maintaining oxygen status and blood pressure, and treating other infections if they occur. Some organizations have suggested the addition of broad-spectrum antimicrobials, particularly in patients with evidence of septic shock.
Medical Therapy
There are no targeted antiviral therapies currently in use. Supportive care is the mainstay of medical management. where hemodynamic and respiratory support are the two most important interventions.
Bleeding
Replete coagulation factors with fresh frozen plasma if available, and transfuse with packed red blood cells and platelets as needed. Invasive procedures should be avoided to prevent further bleeding.
Dehydration and Shock
- Patients with Ebola virus disease should be considered high-risk for development of shock.
- Intravenous fluids should be aggressively administered with careful consideration of electrolyte imbalances.
- Hypokalemia and hypocalcemia are common and repletion of potassium levels and calcium may be necessary.
- A combination of intravenous fluids, vasopressors, and blood products may be necessary as needed.
Hypoxia
Treat with supplemental oxygen including intubation if deemed necessary.
Superimposed Infections
Treating any complicating infections with empiric antimicrobial agents.
Prophylaxis Against Co-infections
It is common practice to administer antibiotics and antimalarial agents for patients with Ebola virus disease due to the high risk of co-infection or super-infection.
References